Product NDC: | 0168-0277 |
Proprietary Name: | Clindamycin Phosphate |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 20 mg/g & nbsp; clindamycin phosphate |
Administration Route(s): | VAGINAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0277 |
Labeler Name: | E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065139 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041227 |
Package NDC: | 0168-0277-40 |
Package Description: | 40 g in 1 TUBE, WITH APPLICATOR (0168-0277-40) |
NDC Code | 0168-0277-40 |
Proprietary Name | Clindamycin Phosphate |
Package Description | 40 g in 1 TUBE, WITH APPLICATOR (0168-0277-40) |
Product NDC | 0168-0277 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | CREAM |
Route Name | VAGINAL |
Start Marketing Date | 20041227 |
Marketing Category Name | ANDA |
Labeler Name | E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 20 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |